Senti Biosciences Holdings, Inc.
SNTI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001854270
No open-market purchases or sales by Senti Biosciences Holdings, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $6.37M in total; no superinvestor holds it.
Holders of 5% or more of SNTI
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Senti Biosciences Holdings, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Celadon Partners SPV 24 | 13D/A | 54.60%25.7M shares | +9.60 ppfrom 45.00% | Mar 13, 20255 filings | May 4, 2026 | SEC |
| Bayer Healthcare LLC | 13D | 19.99%6.14M shares | New | Mar 17, 20251 filing | Mar 17, 2025 | SEC |
| New Enterprise Associates 15, L.P. | 13D/A | 12.10%3.78M shares | −2.40 ppfrom 14.50% | Mar 10, 20252 filings | Mar 31, 2026 | SEC |
| Nantahala Capital Management, LLC | 13G/A | 8.12%2.22M shares | 0.00 ppfrom 8.12% | Feb 14, 20253 filings | May 15, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
16 Schedule 13D and 13G filings on Senti Biosciences Holdings, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| May 4, 20265:00 PM ET | Celadon Partners SPV 24and 2 others | 13D/A | 54.60%25.7M shares | +9.60 ppfrom 45.00% | Apr 27, 2026 | SEC |
| Mar 31, 20265:58 PM ET | New Enterprise Associates 15, L.P.and 6 others | 13D/A | 12.10%3.78M shares | −2.40 ppfrom 14.50% | Mar 27, 2026 | SEC |
| Jan 20, 20264:05 PM ET | Celadon Partners SPV 24and 1 other | 13D/A | 45.00%13.5M shares | 0.00 ppfrom 45.00% | Jan 19, 2026 | SEC |
| Sep 2, 20258:15 AM ET | Celadon Partners SPV 24and 1 other | 13D/A | 45.00%13.4M shares | +7.40 ppfrom 37.60% | Aug 29, 2025 | SEC |
| May 15, 20254:43 PM ET | Nantahala Capital Partners Limited Partnership | 13G/A | 1.90%502.5K shares | −4.01 ppfrom 5.91%Below 5% | Mar 31, 2025 | SEC |
| May 15, 20254:41 PM ET | Nantahala Capital Management, LLCand 2 others | 13G/A | 8.12%2.22M shares | 0.00 ppfrom 8.12% | Mar 31, 2025 | SEC |
| May 15, 20254:36 PM ET | Nantahala Capital Management, LLCand 2 others | 13G/A | 8.12%2.22M shares | −1.87 ppfrom 9.99% | Mar 31, 2025 | SEC |
| May 15, 20253:53 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 4.99%1.44M shares | −5.00 ppfrom 9.99%Below 5% | Mar 31, 2025 | SEC |
| May 7, 20254:26 PM ET | Lonsdale Joeand 3 others | 13G/A | 1.00%253.8K shares | –Below 5% | Mar 31, 2025 | SEC |
| Mar 17, 20256:35 PM ET | Bayer Healthcare LLCand 3 others | 13D | 19.99%6.14M shares | New | Mar 10, 2025 | SEC |
| Mar 17, 20253:01 PM ET | Celadon Partners SPV 24and 1 other | 13D/A | 37.60%9.78M shares | 0.00 ppfrom 37.60% | Mar 6, 2025 | SEC |
| Mar 13, 20254:31 PM ET | Celadon Partners SPV 24and 1 other | 13D | 37.60%9.78M shares | New | Mar 6, 2025 | SEC |
| Mar 10, 20257:00 PM ET | New Enterprise Associates 15, L.P.and 6 others | 13D/A | 14.50%3.78M shares | – | Mar 6, 2025 | SEC |
| Feb 14, 20254:56 PM ET | Armistice Capital, LLCand 1 other | 13G | 9.99%536.0K shares | New | Dec 31, 2024 | SEC |
| Feb 14, 20254:32 PM ET | Nantahala Capital Management, LLCand 2 others | 13G | 9.99%509.3K shares | New | Dec 31, 2024 | SEC |
| Feb 14, 20254:31 PM ET | Nantahala Capital Partners Limited Partnership | 13G | 5.91%301.5K shares | New | Dec 2, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Senti Biosciences Holdings, Inc. shares.
No Form 144 notices for Senti Biosciences Holdings, Inc. are on file.